Abbott, AbbVie Should Pay $5.8M In Humira Suit, Jury Told

Law360, Chicago (May 8, 2013, 5:45 PM EDT) -- An attorney for a man accusing Abbott Laboratories and AbbVie Inc. of failing to adequately warn doctors about the infection risks for their Humira arthritis drug asked an Illinois jury on Wednesday to award his client $5.8 million in damages.

During closing arguments for the two-week trial in Chicago state court, Jim Perdue Jr. of Perdue Kidd & Vickery asked jurors to side with his client, Milton Tietz, on his claims for negligence and strict products liability. However, Abbott attorney Michael Foradas of Kirkland & Ellis...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.